immunotherapy in mds
Published 2 years ago • 124 plays • Length 4:44Download video MP4
Download video MP3
Similar videos
-
1:18
update on immunotherapy in mds
-
1:48
immune therapy approaches in mds
-
2:10
using the innate immune system to treat mds & the value of novel immunotherapies
-
3:47
the role of immunotherapy in the aml treatment landscape
-
1:21
hmas for mds- a party of one
-
2:17
session highlights: practical aspects of immunotherapy in multiple myeloma
-
0:36
the potential of immunotherapies in the myeloma treatment landscape
-
6:11
first-in-human study of the menin-kmt2a inhibitor jnj-75276617 in r/r acute leukemias
-
3:10
the role of ngs in mds diagnosis
-
9:40
acute myeloid leukemia outcomes
-
1:41
an overview of the mds diagnosis pathway
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
1:37
the role of the innate immune system in mds & the value of targeting immune signaling pathways
-
1:21
sequencing of bcma-directed therapies for multiple myeloma
-
1:03
an insight into the sequencing of immunotherapies in adults with all
-
6:24
immuno-oncology approaches in mds
-
1:29
the current landscape of immunotherapy for aml: an update from ash 2023
-
9:41
the i4mds consortium and immune monitoring in mds
-
2:17
insights into the real-world efficacy of luspatercept in patients with lr-mds
-
2:07
emerging targeted treatments for mds
-
3:09
immunotherapy in myeloma - where are we?